Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
25.40
-0.21 (-0.82%)
At close: May 26, 2026, 4:00 PM EDT
25.90
+0.50 (1.97%)
After-hours: May 26, 2026, 7:43 PM EDT
Zymeworks Employees
Zymeworks had 243 employees as of March 31, 2026. The number of employees decreased by 56 or -18.73% compared to the same quarter last year.
Employees
243
Change
-56
Growth
-18.73%
Revenue / Employee
$334,416
Profits / Employee
-$422,453
Market Cap
1.85B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Ascentage Pharma Group International | 767 |
| ADMA Biologics | 647 |
| Lakefront Biotherapeutics NV | 558 |
| Vericel | 398 |
| Ocular Therapeutix | 325 |
| Nurix Therapeutics | 317 |
| Viridian Therapeutics | 252 |
ZYME News
- 12 days ago - Zymeworks authorizes share repurchase program of up to $125M - TheFly
- 12 days ago - Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock - GlobeNewsWire
- 13 days ago - Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 17 days ago - Zymeworks Q1 Earnings Call Highlights - MarketBeat
- 19 days ago - Zymeworks reports Q1 EPS (59c), consensus (10c) - TheFly
- 19 days ago - Zymeworks Earnings Call Transcript: Q1 2026 - Transcripts
- 19 days ago - Zymeworks Earnings release: Q1 2026 - Filings
- 19 days ago - Zymeworks Slides: Q1 2026 - Filings